Faculty, Staff and Student Publications
Publication Date
10-1-2022
Journal
Journal of Applied Clinical Medical Physics
Abstract
PURPOSE: We investigated the feasibility of thoracic spine stereotactic body radiotherapy (SBRT) using the Elekta Unity magnetic resonance-guided linear accelerator (MRL) in patients who received prior radiotherapy. We hypothesized that Monaco treatment plans can improve the gross tumor volume minimum dose (GTVmin) with spinal cord preservation and maintain consistent plan quality during daily adaptation.
METHODS: Pinnacle clinical plans for 10 patients who underwent thoracic spine SBRT (after prior radiotherapy) were regenerated in the Monaco treatment planning system for the Elekta Unity MRL using 9 and 13 intensity-modulated radiotherapy (IMRT) beams. Monaco adapt-to-position (ATP) and adapt-to-shape (ATS) workflow plans were generated using magnetic resonance imaging with a simulated daily positional setup deviation, and these adaptive plans were compared with Monaco reference plans. Plan quality measures included target coverage, Paddick conformity index, gradient index, homogeneity index, spinal cord D
RESULTS: GTVmin values from the Monaco 9-beam and 13-beam plans were significantly higher than those from Pinnacle plans (p < 0.01) with similar spinal cord dose. Spinal cord D
CONCLUSION: These findings show that MRL plans for thoracic spine SBRT are safe and feasible, allowing tumor dose escalation with spinal cord preservation and consistent daily plan adaptation using the ATS workflow. Careful plan review of hot spots and lung dose is necessary for safe MRL-based treatment.
Keywords
Humans, Radiosurgery, Re-Irradiation, Radiotherapy Planning, Computer-Assisted, Spinal Neoplasms, Particle Accelerators, Radiotherapy, Intensity-Modulated, Magnetic Resonance Imaging, Adenosine Triphosphate, Radiotherapy Dosage, dosimetry, MR‐Linac, spine SBRT
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Health and Medical Physics Commons, Medical Sciences Commons, Oncology Commons
Comments
PMID: 36004700